Gland Pharma opened at ₹3,078.40, in line with its previous close of ₹3,078.40. During today's session, the stock has traded between ₹3,040.00 and ₹3,105.00, with an average traded price of ₹3,076.45. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Gland Pharma is now worth
₹ 8,158.00
resulting in a loss of
₹ 1,842.00 (18.42%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+12.70 (+0.41%)
Day High
₹3,105.00
Day Low
₹3,040.00
Day Open
₹3,078.40
Prev Close
₹3,078.40
Volume
2,07,496
Value Traded
₹63.84 Cr
1W Return
6.17%
1M Return
5.78%
3M Return
24.67%
6M Return
77.46%
1Y Return
60.71%
Market Cap (₹ Cr.)
51,007
PE Ratio
45.00
PB Ratio
4.91
Dividend Yield
0.65%
ROE
9.92%
ROCE
13.74%
Book Value (₹)
627.71
Face Value (₹)
1.00
EPS (TTM)
19.23
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
6.17%
6 Week
-
1 Month
5.78%
3 Month
24.67%
9 Month
81.51%
Gland Pharma sets e-voting for Wang appointment; $21m US investment approved
E-voting for Xingli Wang's directorship runs from October 7 to November 5, 2026. Results for the postal ballot on Wang's appointment due by November 9, 2026. Gland Pharma approved $21 million investment in US subsidiary for Novelstar acquisition. Wang appointed as Additional Director on October 1, 2026, replacing Wenjie Zhang.
7 days agoMirae Asset cuts Gland Pharma stake to 2.95% after open market sale
Mirae Asset Mutual Fund sold 57,842 Gland Pharma shares on September 28, 2026. Stake reduced from 2.99% to 2.95% of total equity capital. Remaining holding stands at 4,872,191 shares. Sale executed through the open market.
13 days agoGland Pharma shares worth ₹29.27 crore change hands in large trade
A large-trade signal flagged approximately 1,00,068 Gland Pharma shares changing hands on BSE. The trades clustered near ₹2924.55 per share, for a combined value of ₹29.27 crore. This is a real-time signal from a trade-scanning system, not a confirmed exchange-reported event. Official bulk and block deal disclosures are published by NSE/BSE only after market close.
19 days agoGland Pharma pays ₹1.40 lakh fine for technical breach of director norms
Gland Pharma paid a total penalty of ₹1.40 lakh to NSE and BSE. The fine relates to a 34-day technical breach of SEBI LODR Regulation 17(1A). Each exchange levied a fine of ₹70,000 excluding applicable GST. The company settled the full amount suo motu ahead of final notice receipt.
1mo agoGland Pharma schedules analyst and institutional investor meetings for September 2026
Gland Pharma disclosed its September 2026 analyst and investor meeting schedule. One-on-one meetings are set with East Bridge Capital, IIFL Capital, and Antique Broking. A group meeting arranged by Nomura is scheduled for September 25, 2026. The disclosure was made pursuant to SEBI Regulation 30 listing requirements.
1mo agoFosun Pharma sells 6% stake in Gland Pharma via open market
Fosun Pharma Industrial Pte. Ltd. sold 98,97,000 Gland Pharma shares via open market. The 6.00% stake disposal was executed on September 4, 2026. Promoter holding falls from 51.76% to 45.76% of voting capital. Diluted stake reduces from 51.36% to 45.41%. Total equity capital remains at 1,64,966,661 shares.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Gland Pharma is now worth
₹ 8,158.00
resulting in a loss of
₹ 1,842.00 (18.42%)
Note: Past profits do not guarantee future returns.
